Skip to main navigation
Skip to search
Skip to main content
Johns Hopkins University Home
Search content at Johns Hopkins University
Home
Profiles
Research units
Research output
Biochemical markers in cancer of the breast
D. C. Tormey
, T. P. Waalkes
School of Medicine
Research output
:
Contribution to journal
›
Review article
›
peer-review
6
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Biochemical markers in cancer of the breast'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Breast Cancer
100%
In Cancer
100%
Metastatic Disease
100%
Biochemical Markers
100%
High Risk
50%
Clinical Application
50%
Elevated Levels
50%
Breast Cancer Patients
25%
Postoperative Setting
25%
Postoperative Patients
25%
Tumor Antigen
25%
Combination Chemotherapy
25%
Tumor Burden
25%
Ferritin
25%
Subclinical Disease
25%
Screening Setting
25%
Specific Marker
25%
Specific Tests
25%
Breast Tissue
25%
Relapse Risk
25%
Casein
25%
Hydroxyproline
25%
Synthesis Pathway
25%
Risk for Relapse
25%
Matrix Approach
25%
Milk Synthesis
25%
Diagnostic Setting
25%
Status Report
25%
Single-marker Test
25%
Nursing and Health Professions
Malignant Neoplasm
100%
Carcinoembryonic Antigen
100%
Biochemical Marker
100%
Economic and Social Development
100%
Breast Cancer
50%
Tumor Volume
50%
Sensitivity and Specificity
50%
Ferritin
50%
Tumor Antigen
50%
Combination Chemotherapy
50%
Casein
50%
Hydroxyproline
50%
Diseases
50%
Medicine and Dentistry
Malignant Neoplasm
100%
Metastatic Carcinoma
100%
Biochemical Marker
100%
Carcinoembryonic Antigen
50%
Breast Cancer
25%
Neoplasm
25%
Clinician
25%
Sensitivity and Specificity
25%
Tumor Antigen
25%
Ferritin
25%
Combination Chemotherapy
25%
Breast Tissue
25%
Casein
25%
Hydroxyproline
25%
Diseases
25%
Biochemistry, Genetics and Molecular Biology
Carcinoembryonic Antigen
100%
Tumor Antigen
50%
Tumor Volume
50%
Ferritin
50%
Casein
50%
Combination Chemotherapy
50%
Neuroscience
Carcinoembryonic Antigen
100%
Ferritin
50%
Casein
50%
Tumor Antigen
50%
Chemotherapy
50%
Hydroxyproline
50%